Latest Breaking News On - ஐரோப்பிய கலைக்கழகம் ஆஃப் ஒவ்வாமை - Page 12 : comparemela.com

Eating a Nic's Keto Healthy Fatty Diet Reduce Body Weight and Improve Cardiovascular Health Markers!

The study s findings have shown that participants had a significant 4.41% reduction in body fat percentage. Participants body weight was significantly reduced by 8.55kg. After five months of adherence to the diet plan, participants showed a significant decrease in their total cholesterol and LDL cholesterol, an increase in the HDL cholesterol, the good cholesterol, and a significant reduction in blood sugar levels. Overall, the study results suggest that Nic s Keto Diet may be used to improve body composition and markers of cardiovascular health. Professor Nikolaos Tzenios is a Professor of Public Health, Fellow of The Royal Society for Public Health (UK), Fellow of the AMERICAN ACADEMY OF ANTI-AGING MEDICINE, ASSOCIATE ACADEMICIAN of the International Academy of Social Sciences, Member of the American Academy of Regenerative Medicine, Member of The European Academy of Allergy and Clinical Immunology, Member of the Royal Society of Biology and a Postgraduate student at Global

United-states
Canada
United-kingdom
London
City-of
American
Nikolaos-tzenios
Professor-of-public-health
Member-of-the-royal-society-biology
Harvard-medical-school
Department-of-postgraduate-medical-education
Global-clinical-scholars-research-training-program

Nature article presents impact and importance of epithelial barrier damage on a range of common diseases

Nature article presents impact and importance of epithelial barrier damage on a range of common diseases News provided by Share this article STOCKHOLM, April 15, 2021 /PRNewswire/ SciBase Holding AB ( SciBase ) [STO:SCIB], a leading developer of augmented intelligence-based solutions for skin disorders, announced today the publication of a groundbreaking article presenting the epithelial barrier hypothesis in Nature Reviews Immunology. The article was written by Professor Cezmi Akdis at the Swiss institute of Allergy and Asthma Research (SIAF). Prof. Akdis is the key research collaborator in SciBase s product development for skin barrier assessment. The article presents the background for the steep increase in allergic diseases over the last decades, and how this increase is connected to industrialization and modern lifestyle.

Davos
Switzerland-general
Switzerland
Sweden
Australia
Zurich
Züsz
United-states
Stockholm
Swiss
Cezmi-akdis
Simon-grant

Nature article presents impact and importance of epithelial barrier damage on a range of common diseases

Nature article presents impact and importance of epithelial barrier damage on a range of common diseases
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

Davos
Switzerland-general
Switzerland
Sweden
Australia
Zurich
Züsz
United-states
Stockholm
Swiss
Cezmi-akdis
Simon-grant

Украинский конфликт: Вашингтон призывает Киев к сдержанности, понимая, чем всё может кончиться

Украинский конфликт: Вашингтон призывает Киев к сдержанности, понимая, чем всё может кончиться
argumenti.ru - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from argumenti.ru Daily Mail and Mail on Sunday newspapers.

Black-sea
Oceans-general
Oceans
Arizona
United-states
Kiev
Ukraine-general
Ukraine
Washington
Russia
Turkey
Turks

New clinical study shows Nevisense potential for assessment of Skin Barrier and Atopic Dermatitis

New clinical study shows Nevisense potential for assessment of Skin Barrier and Atopic Dermatitis News provided by Share this article STOCKHOLM, April 12, 2021 /PRNewswire/ SciBase Holding AB ( SciBase ) [STO:SCIB], a leading developer of augmented intelligence-based solutions for skin disorders, announced today the publication of a new clinical study supporting SciBase s strategy to develop multiple clinical applications for the Nevisense and Nevisense Go platforms. The study is from the Swiss institute of Allergy and Asthma Research (SIAF) and has been published in the European Journal of Allergy and Clinical Immunology (Allergy). In the study Nevisense was used to assess the skin barrier of patients with atopic dermatitis (AD) and could accurately detect signs of atopic dermatitis even on unaffected skin. The Nevisense measurement also correlated with relevant biomarkers for atopic dermatitis.

Sweden
Australia
Zurich
Zusz
Switzerland
United-states
Davos
Switzerland-general
Stockholm
Swiss
Cezmi-akdis
Simon-grant